A Study to Evaluate the Effect of Hepatic Impairment on the Pharmacokinetics of Erdafitinib
Clinical trial NCT03587363 · TERMINATED
Trial details
- NCT number
- NCT03587363
- Sponsor
- Janssen Research & Development, LLC
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-06
- Primary completion
- 2020-12-22
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.